Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-15-081134

Vice President, Finance acquired 4,358 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Ames Constance · Vice President, Finance

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-11-24 Conversion : show line 1 in the form +4,358 $5.94 $25,887 4,358 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2015-11-24 Grant or award : show line 2 in the form 8% Convertible Note +4,358 0 D
Loading xslF345X03/a4.xml…